During the past decade, University Hospital Jena conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 3 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Jena" #1 sponsor was "Jena University Hospital" with 24 trials, followed by "University of Jena" with 8 trials sponsored, "Amylyx Pharmaceuticals Inc." with 2 trials sponsored, "Center for Sepsis Control and Care, Germany" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Jena" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Charite University, Berlin, Germany" with 3 trials as a collaborator, "GE Healthcare" with 3 trials as a collaborator, "Ruhr University of Bochum" with 3 trials as a collaborator and "University of Jena" with 3 trials as a collaborator. Other collaborators include 190 different institutions and companies that were collaborators in the rest 178 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Jena" are "Coronary Artery Disease" (5 trials), "Heart Diseases" (4 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "COVID-19" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "University Hospital Jena" in a lesser frequency.

Most popular intervention types in "University Hospital Jena" are "Drug" (24 trials), "Other" (19 trials), "Device" (12 trials), "Procedure" (10 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AMX0035" (2 trials), "Multiple arterial grafting" (2 trials), "Single arterial graft" (2 trials) and "(1,3)-β-D-glucan guided therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Jena" are 76 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 38 active trials in "University Hospital Jena". 1 are not yet recruiting, 27 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 31 completed trials in University Hospital Jena, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Jena, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 18 trials that are defined as “Not Applicable".